Pharmalot By Ed Silverman Biogen to pay $22 million for illegally using charities to pay kickbacks to Medicare patients
Pharmalot By Ed Silverman Sackler family members deny responsibility for the opioid crisis in a rare public appearance
Pharmalot By Ed Silverman Former J&J exec sues for sexual discrimination and harassment, alleging ‘ruthless pattern of retaliation’
Pharmalot By Ed Silverman Pharmalittle: Hospitals grapple with extra dose of Pfizer vaccine; FDA panel meets to review Moderna vaccine
Pharmalot By Ed Silverman AbbVie wins 21 months of wrinkle-free competition for Botox thanks to an ITC ruling
Pharmalot By Ed Silverman Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’
Pharmalot By Ed Silverman Pharmalittle: One-quarter of the world won’t have a Covid-19 shot until 2022; naming a Covid vaccine takes time
Pharmalot By Ed Silverman Pharmalittle: FDA finds Moderna vaccine effective; Trump drug discount card gets new life
Pharmalot By Ed Silverman State attorneys general urge HHS to penalize drug makers for cutting discounts to hospitals
Pharmalot By Ed Silverman Sackler family members agree to testify at House hearing on Purdue’s role in opioid crisis
Pharmalot By Ed Silverman Pharmalittle: FDA’s Hahn insists Pfizer vaccine was authorized as soon as possible; AstraZeneca to pay $39 billion for Alexion
Pharmalot By Ed Silverman Hospital groups sue HHS for failing to stop drug makers from cutting medication discounts
Pharmalot By Ed Silverman World Trade council fails to act on proposal to waive IP rights to Covid-19 drugs and vaccines
Pharmalot By Ed Silverman A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea
Pharmalot By Ed Silverman Pharmalittle: FDA panel endorses Pfizer Covid-19 vaccine; meanwhile, Sanofi shot suffers major setback
Pharmalot By Ed Silverman In a petition, Boehringer warns FDA its definition of ‘strength’ threatens biosimilar competition
Pharmalot By Ed Silverman Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers
Pharmalot By Ed Silverman Pharmalittle: FDA advisers reviewing Pfizer Covid-19 vaccine today; White House hits roadblock on drug discount cards
Pharmalot By Ed Silverman Florida finds pharmacy benefit managers are benefiting from a lucrative profit center
Pharmalot By Ed Silverman Pharmalittle: AstraZeneca missteps undermined faith in its Covid-19 vaccine; U.S. jockeys with other countries for Pfizer shot
Pharmalot By Ed Silverman Federal watchdog urged to investigate the FDA’s handling of Biogen Alzheimer’s drug
Pharmalot By Ed Silverman Pharmalittle: FDA staff backs Pfizer Covid-19 vaccine; Trump administration failed to lock in larger vaccine supply
Pharmalot By Ed Silverman Families tell U.N. Vertex is violating human rights with cystic fibrosis drug pricing
Pharmalot By Ed Silverman FDA finds fault with a Bristol plant, but it may not upset key approval of a cancer drug
Pharmalot By Ed Silverman Pharmalittle: Biden taps HHS and CDC heads; U.S. taxpayers may get a payback on Gilead’s remdesivir
Pharmalot By Ed Silverman A payoff for U.S. taxpayers? CDC may have claims on remdesivir patents held by Gilead
Pharmalot By Ed Silverman FTC says the number of pay-to-delay cases remains low, but vows to keep watch